Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Consulting agrmnt
Rezolute, Inc. (RZLT) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 8-K Quarterly results
10/13/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/06/2023 4 ROBERTS BRIAN KENNETH (Chief Medical Officer) has filed a Form 4 on Rezolute, Inc.
Txns: Bought 5,000 shares @ $1.8999, valued at $9.5k
06/02/2023 8-K Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics, Financial Statements and Exhib...
Docs: "Board”) of Rezolute, Inc. adopted this Code of Business Conduct and Ethics (the “Code"
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Quarterly results
Docs: "Rezolute Reports Third Quarter Fiscal 2023 Results and Highlights Company Progress"
05/03/2023 SC 13D/A Genexine Inc. reports a 5% stake in Rezolute, Inc.
02/14/2023 SC 13G FIRST MANHATTAN CO reports a 8.5% stake in Rezolute, Inc.
02/14/2023 SC 13G/A CAXTON CORP reports a 5% stake in Rezolute, Inc.
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 10-Q Quarterly Report for the period ended December 31, 2022
02/10/2023 8-K Quarterly results
02/01/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/13/2023 8-K Quarterly results
12/15/2022 8-K Quarterly results
11/09/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/09/2022 8-K Quarterly results
Docs: "Rezolute, Inc. Condensed Consolidated Financial Statements Data"
11/07/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
10/28/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
09/15/2022 10-K Annual Report for the period ended June 30, 2022
09/15/2022 8-K Quarterly results
Docs: "Rezolute Reports Fourth Quarter and Full Year Fiscal 2022 Results and Highlights Company Progress"
07/05/2022 EFFECT Form EFFECT - Notice of Effectiveness:
07/01/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
07/01/2022 8-K Quarterly results
06/28/2022 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
06/28/2022 4 Kim Young-Jin (Director) has filed a Form 4 on Rezolute, Inc.
Txns: Granted 40,000 options to buy @ $3.4, valued at $136k
06/27/2022 4 FAUCHET PHILIPPE (Director) has filed a Form 4 on Rezolute, Inc.
Txns: Granted 80,000 options to buy @ $3.4, valued at $272k
06/27/2022 4 ROBERTS BRIAN KENNETH (Sr VP, Clinic Development) has filed a Form 4 on Rezolute, Inc.
Txns: Granted 700,000 options to buy @ $3.4, valued at $2.4M
06/27/2022 4 Hogenhuis Wladimir (Director) has filed a Form 4 on Rezolute, Inc.
Txns: Granted 80,000 options to buy @ $3.4, valued at $272k
06/27/2022 4 Elam Nevan C (CEO) has filed a Form 4 on Rezolute, Inc.
Txns: Granted 2,600,000 options to buy @ $3.4, valued at $8.8M
06/27/2022 4 Labrucherie Gil M (Director) has filed a Form 4 on Rezolute, Inc.
Txns: Granted 80,000 options to buy @ $3.4, valued at $272k
06/27/2022 4 KREHER NERISSA (Director) has filed a Form 4 on Rezolute, Inc.
Txns: Granted 80,000 options to buy @ $3.4, valued at $272k
06/27/2022 SC 13G ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 8.8% stake in Rezolute Inc.
06/17/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy